|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89.5 USD | -1.64% |
|
-3.05% | +17.38% |
| Jul. 15 | Sector Update: Health Care Stocks Edge Lower Late Afternoon | MT |
| Jul. 15 | Sector Update: Health Care Stocks Retreat Monday Afternoon | MT |
Edwards Lifesciences Corporation (NYSE:EW) agreed to acquire the remaining unknown majority stake in Innovalve Bio Medical Ltd. for $300 million on July 15, 2024. The consideration of $300 million will be paid in cash at the closing of the acquisition. Upon completion, Innovalve will join the transcatheter mitral and tricuspid therapies (TMTT) product group, led by corporate vice president, Daveen Chopra.
The acquisition is expected to close by the end of 2024.
| 1st Jan change | Capi. | |
|---|---|---|
| +17.38% | 54.83B | |
| +2.62% | 209B | |
| +6.44% | 183B | |
| +29.61% | 158B | |
| +34.96% | 114B | |
| +3.84% | 67.29B | |
| -4.51% | 46.88B | |
| -5.77% | 38.58B | |
| +3.71% | 36.65B | |
| +19.35% | 30.09B |
EDWARDS LIFESCIENCES CORPORATION 
